Somewhat Positive Media Coverage Somewhat Unlikely to Impact Perrigo (PRGO) Stock Price
News stories about Perrigo (NYSE:PRGO) have trended somewhat positive recently, according to Accern Sentiment. The research group identifies positive and negative media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Perrigo earned a news sentiment score of 0.24 on Accern’s scale. Accern also gave news articles about the company an impact score of 45.7487939634253 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.
These are some of the news articles that may have effected Accern Sentiment Analysis’s rankings:
- Perrigo Company (PRGO) Stock Rating Upgraded by BidaskClub (americanbankingnews.com)
- Perrigo Scores Relative Strength Rating Upgrade; Hits Key Threshold (finance.yahoo.com)
- Perrigo Company (PRGO) EVP Sells $321,716.55 in Stock (americanbankingnews.com)
- Deutsche Bank AG Increases Perrigo Company (PRGO) Price Target to $95.00 (americanbankingnews.com)
- Perrigo Company Reaches Analyst Target Price – Nasdaq (nasdaq.com)
Perrigo (NYSE:PRGO) traded down 2.22% during midday trading on Friday, reaching $86.90. 3,571,502 shares of the company traded hands. The stock’s market capitalization is $12.39 billion. The company has a 50 day moving average price of $77.62 and a 200-day moving average price of $73.23. Perrigo has a one year low of $63.68 and a one year high of $99.14.
Perrigo (NYSE:PRGO) last posted its quarterly earnings results on Thursday, August 10th. The company reported $1.22 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.94 by $0.28. The company had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.18 billion. Perrigo had a negative net margin of 51.04% and a positive return on equity of 11.55%. The firm’s revenue was down 7.7% compared to the same quarter last year. During the same quarter last year, the firm posted $1.93 EPS. Analysts forecast that Perrigo will post $4.58 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 12th. Investors of record on Friday, August 25th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 0.74%. The ex-dividend date of this dividend was Wednesday, August 23rd. Perrigo’s dividend payout ratio is presently -3.51%.
PRGO has been the topic of a number of analyst reports. Royal Bank Of Canada set a $60.00 price objective on shares of Perrigo and gave the company a “sell” rating in a research report on Sunday, July 16th. Goldman Sachs Group, Inc. (The) restated a “sell” rating and issued a $68.00 price objective on shares of Perrigo in a research report on Wednesday, May 31st. Deutsche Bank AG restated a “buy” rating and issued a $88.00 price objective (up previously from $86.00) on shares of Perrigo in a research report on Monday, July 17th. Canaccord Genuity set a $86.00 price objective on shares of Perrigo and gave the company a “buy” rating in a research report on Monday, May 22nd. Finally, BidaskClub upgraded shares of Perrigo from a “sell” rating to a “hold” rating in a research report on Tuesday, June 20th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eight have assigned a buy rating to the company. Perrigo has a consensus rating of “Hold” and a consensus target price of $89.36.
In other Perrigo news, EVP Thomas Farrington sold 616 shares of the firm’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $76.90, for a total transaction of $47,370.40. Following the transaction, the executive vice president now owns 2,724 shares of the company’s stock, valued at approximately $209,475.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Jeffrey Needham sold 3,595 shares of the firm’s stock in a transaction dated Tuesday, September 12th. The shares were sold at an average price of $89.49, for a total transaction of $321,716.55. Following the transaction, the executive vice president now directly owns 10,118 shares in the company, valued at approximately $905,459.82. The disclosure for this sale can be found here. Insiders sold a total of 6,894 shares of company stock worth $581,320 in the last ninety days. 6.90% of the stock is currently owned by insiders.
Perrigo Company Profile
Perrigo Company plc is a global healthcare supplier that develops, manufactures and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, infant formulas, nutritional products, animal health, dietary supplements, active pharmaceutical ingredients (API), and medical diagnostic products, and Multiple Sclerosis drug Tysabri.
Receive News & Ratings for Perrigo Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo Company and related companies with MarketBeat.com's FREE daily email newsletter.